Generate a tailored SOP for Dr. Benedict Albensi. Improve your application with a focused, well-structured draft.
Dr. Benedict Albensi is a professor of pharmacology and therapeutics at Max Rady College of Medicine and a principal investigator at St. Boniface Hospital Research Centre. He holds research affiliations as a research scientist at the Children's Hospital Research Institute of Manitoba and as a research affiliate at the University of Manitoba Centre on Aging. He was awarded a postdoctoral fellowship at Georgetown University, where he worked on MRI methods for investigating head trauma and cognition. He then completed work at the Sanders-Brown Center on Aging at the University of Kentucky, where he was the first to demonstrate the necessity of nuclear factor kappa B (NF-kB) for synaptic plasticity in mammals. His appointments also include positions at Cleveland Clinic, NPS Pharmaceuticals, Pfizer, and Case Western Reserve University. His research primarily focuses on aging, Alzheimer's disease, dementia, brain injury, and energy metabolism, particularly the role of NF-kB in inflammation and memory. Dr. Albensi's contributions have led to significant advancements in the development of new therapies for neurodegenerative conditions. He has been recognized as a leader in his field, with numerous awards and a notable publication record in top-ranked scientific journals.
Max Rady College of Medicine • University of Manitoba, Winnipeg
Professor in the Max Rady College of Medicine focusing on pharmacology and therapeutics.
Streams include Education, Administration, or Clinical.